Evidence map›Paper›PMID 39669221›Full record

ArticleJournal of oral microbiology2025

Activation of cellular responses by cyclic dinucleotides and

Samira Elmanfi, Kenneth I Onyedibe, Uma K Aryal, Eija Könönen, Herman O Sintim, Ulvi Kahraman Gürsoy

Abstract read
In one paragraph

Article in Journal of oral microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. New advances in oral microbiology and tumor research.World journal of clinical oncology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samira ElmanfiDepartment of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.
Kenneth I OnyedibeDepartment of Chemistry, Purdue University, West Lafayette, USA.
Uma K AryalPurdue Proteomics Facility, Bindley Bioscience Center, Purdue University, West Lafayette, USA.
Eija KönönenDepartment of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.
Herman O SintimDepartment of Chemistry, Purdue University, West Lafayette, USA.ORCID https://orcid.org/0000-0002-2280-9359
Ulvi Kahraman GürsoyDepartment of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.ORCID https://orcid.org/0000-0002-1225-5751

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bacterial cyclic dinucleotides (CDNs), cyclic di-guanosine monophosphate (c-di-GMP), and cyclic di-adenosine monophosphate (c-di-AMP) upregulate interferon signaling proteins of human gingival fibroblasts (HGFs). However, the simultaneous effect of bacterial CDNs and lipopolysaccharides (LPS) on the HGF proteome is unknown. Aim: The aim was to apply an unbiased proteomics approach to evaluate how simultaneous exposure to CDNs and Methods: The proteomic responses of HGFs were examined under three different treatment conditions (c-di-AMP+Pg LPS, c-di-GMP+Pg LPS, and Pg LPS alone) by label-free quantitative mass spectrometry analysis. Results: Simultaneous exposure to CDNs and Pg LPS significantly upregulated innate immunity-related and interferon signaling-related proteins, such as ubiquitin-like protein ISG15 (ISG15), deoxynucleoside triphosphate triphosphohydrolase (SAMHD1), interferon regulatory factor 9 (IRF-9), interferon-induced GTP-binding protein Mx (MX)1, and MX2. Interferon signaling pathway was the most significantly regulated canonical pathway in both CDN treatment groups. Conclusion: Simultaneous exposure to CDNs and Pg LPS stimulates the periodontal immune response by activating the anti-microbial cellular responses of HGFs with some notable differences from individual exposures.

Indexed as

cyclic dinucleotideshuman gingival fibroblastsinnate immune responseinterferon signalingLipopolysaccharideporphyromonas gingivalisproteomic analysis

Identifiers

PMID39669221
PMCPMC11632945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.